Clinical Trials

Our clinical grade LaNeo™ MDMA product

PharmAla Biotech is the only company currently sourcing clinical grade LaNeo™ MDMA drug substance in North America. PharmAla’s LaNeo™ MDMA is encapsulated under GMP conditions and is available to entities with Controlled Substances licenses, Section 56 Ministerial Exemptions, or Clinical Trial numbers within Canada. Drug Products can also be exported for use by clinical trial practitioners globally, subject to the issuance of import and export permits.

 

Interested in learning more about our GMP, clinical grade drug product?